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Abstract 
Human articular chondrocytes lose their native phenotype when expanded in traditional 
monolayer cultures.  As a consequence, hydrogel encapsulation has been investigated as a 
means to maintain natural phenotype. Alginate has been widely used for cartilage 
engineering as it has been shown to enable the recovery of a native collagen type II 
expressing chondrocyte phenotype.  This study has evaluated whether the capacity of the 
materials to maintain/revert phenotype is due to the composition of the material or the 
physical entrapment provided by the gel.  To achieve this, an alginate “fluid gel” (a shear-
thinning structured gel system) was produced of identical chemistry to a traditionally gelled 
alginate structure.  Both were seeded with passaged primary human articular chondrocytes. 
Chondrocytes in quiescent alginate showed recovery of the native phenotype and a 
spherical morphology. Chondrocytes in alginate fluid gel were unable to maintain a 
recovered phenotype despite having spherical morphology and were shown to have a lower 
level of entrapment than those in quiescent alginate. These findings indicate that geometric 
entrapment is essential to maintenance of a recovered chondrocyte phenotype in alginate. 
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Introduction 
 
Osteoarthritis (OA) affects 25% of the over-50 population, which is expected to rise with the 
increasingly obese world population. 1,2. OA is characterized by the degeneration of 
articular cartilage, narrowing of the joint space and pathological changes to subchondral 
bone; it is a painful and disabling condition 3. At present, there is no cure for OA and many 
patients will eventually require joint replacement surgery. The native cartilage matrix is rich 
in collagen type II, proteoglycans and chondrocytes, the cartilage-matrix producing cells 4. 
Critically, articular cartilage is avascular and hence has a limited capacity for self-
regeneration. Indeed, it is widely believed that in end-stage OA the cartilage loss is 
irreversible.  Furthermore, as an avascular tissue the delivery of pharmacological entities to 
the cells of the cartilage, the chondrocytes, is highly challenging. 
 
An alternative to the pharmacological approaches being investigated to prevent OA 
progression is the surgical repair of focal defects in cartilage tissue in patients with early-
stage OA, via autologous chondrocyte implantation (ACI) 5. This repair strategy is 
dependent on the expansion of chondrocytes in vitro before re-implantation into the defect 
site 6. Critically, expansion in 2D monolayer culture causes chondrocytes to rapidly de-
differentiate, with a marked loss of their expression of Type II Collagen, aggrecan and 
proteoglycan, and an associated increase in the expression of Type I Collagen 7–9. This loss 
of chondrogenicity leads to the formation of an inferior hyaline cartilage, rich in collagen 
type I, which has been reported to functionally similar to the fibro-cartilage that is formed 
following micro-fracture surgery 10. Consequently, this has meant that the ACI process has 
been of limited success. Therefore, there is a need to develop an improved method for the 
expansion of chondrocytes in vitro, which can maintain the chondrocyte phenotype, and 
thus promote regeneration of functional articular cartilage. 
 
Hydrogels have traditionally been used in regenerative medicine to act as extracellular 
matrix mimics due to their high water content and high degree of tuneability 11,12. One such 
hydrogel is alginate, a linear, un-branched polysaccharide derived from brown algae that 
has been used in drug delivery, wound healing and tissue regeneration 13. Formed of β-D-
mannuronic acid (M) and α-L-guluronic acid (G) residues arranged either in blocks 
(GGG/MMM) or alternating sequences (GMGMGM) 13, alginate undergoes ionotropic 
gelation upon introduction of divalent cations to form crosslinks between G residues 
resulting in an ‘egg-box’ structure 14–16. 
 
Previously, alginate has been shown to maintain chondrocyte phenotype, and to drive bone 
marrow derived mesenchymal stem cells towards a chondrogenic phenotype 17–20. Whether 
this is due to the physical entrapment of the chondrocytes in a 3D scaffold or due to the 
chemical influence of alginate is relatively unknown. The formation of a cartilage matrix by 
the encapsulation of allogenic chondrocytes is a promising approach to produce cartilage 
for surgical implantation. 
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In this study, the influence of the physical entrapment of the alginate on the embedded 
chondrocytes has been investigated by comparing markers of cartilage matrix formation 
when chondrocytes are embedded in an alginate gel and between the particles that are 
formed in an alginate fluid gel.  Fluid hydrogels are produced through the introduction of 
shear during gelation, resulting in the production of microparticles of gel 21–24. The 
microparticles interact with one another and in doing so thicken in the absence of external 
shear stress and hence could be utilized in an injectable therapeutic solution for delivery of 
chondrocytes to defects in articular cartilage. The cells dispersed within this structure are 
not physically entrapped as they would be in a normal, quiescently gelled structure, instead 
they are suspended between fragments of crosslinked alginate (Figure 1).  They are, 
however, exposed to the same chemical stimuli. The aim of this study was therefore to 
determine the effect of different levels of encapsulation on chondrocyte viability, 
morphology and phenotype by comparing quiescent and fluid alginate. 
 
 
Figure 1. Schematic of cells A) encapsulated in quiescent alginate and B) suspended 
between fragmented alginate fluid gel. 
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Results 
 
1. Primary articular chondrocytes cultured in quiescently gelled alginate retain their 
viability and chondrogenic phenotype 
We first examined the effect of traditional monolayer culture on the chondrogenic 
phenotype of primary hACs. Freshly isolated (FI) primary hACs were found to express high 
amounts of type II collagen and low amounts of type I collagen, as determined by qRT-PCR 
analysis of COL2A1 and COL1A1 mRNA expression (Fig. 2A).  As expected, upon culturing 
in monolayer primary hACs rapidly de-differentiated, adopting a more fibroblast-like 
morphology (Fig. 2B), and by passage 3 exhibited significantly reduced (P<0.01) 
expression of type II collagen (Fig. 2A).  Indeed, the expression profile of type I and type II 
Collagen in passaged primary hACs was similar to that observed in the chondrocyte TC28 
cell line (Fig. 2C). 
 
Figure 2. A) Relative mRNA expression of collagen types I and II in primary human 
chondrocytes either directly after isolation from cartilage or following 3 passages in 
monolayer. B) Passage 3 human chondrocytes exhibiting a fibroblast-like morphology (SB: 
200m, C) relative mRNA expression of collagen types I and II in the TC28 human 
chondrocyte cell line. **P<0.005. 
 
Next, we examined the effect of encapsulating primary hACs in quiescent alginate on both 
cell viability and chondrogenic phenotype over a period of 2 weeks. Following 14 days of 
encapsulation in alginate, cells in the scaffolds were stained using a live/dead stain (Calcein 
AM/ethidium homodimer-1 stain). Encapsulated primary hACs showed high levels of cell 
viability and displayed a flattened morphology at the edge of the constructs and a spherical 
morphology in the centre (Fig. 3A and 3B). This is similar to chondrocytes in native 
cartilage, in contrast to the fibroblast-like morphology of primary hACs cultured in 
monolayer.  Analysis of COL2A1 and COL1A1 mRNA expression over a timecourse of 14 
days showed that primary hACs encapsulated in quiescent alginate did not de-differentiate, 
since type II collagen expression was maintained throughout.  Furthermore, encapsulation 
of the TC28 chondrocyte cell line in quiescent alginate suggests that they can be re-
differentiated to a more native chondrocyte collagen phenotype (Fig. 3C and 3D).  In 
addition to measurements of collagen expression, the release of sulphated 
glycosaminoglycan (sGAG) side-chains was quantified over a timecourse of 30 days, as a 
marker of aggrecan proteoglycan turnover in the alginate scaffolds.  Relative to alginate 
without cells, scaffolds containing encapsulated primary hACs or TC28s showed a 
significant accumulation of sGAG secretion over a period of 30 days, suggesting that 
alginate encapsulation supported and maintained aggrecan proteoglycan production (Fig. 
3E). 
 
The ability of quiescent alginate to support an anabolic chondrocyte phenotype, which 
produces cartilage extracellular matrix components, was then further validated by 
histochemical staining of alginate scaffolds. Aggrecan staining was observed in the 
cytoplasmic region of the chondrocytes (Fig. 3F). 
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Figure 3. A) Primary human chondrocytes encapsulated in quiescent alginate showing 
flattened morphology at the edge of the construct and spherical morphology in the centre of 
the construct, SB: 200m. B) z-stack demonstrating cell morphology in 3-D, SB: 100m. C) 
Relative expression of collagen types I and II in TC28s and primary human chondrocytes 
(hAC) throughout 9 and 14 days of culture respectively with collagen type II to type I ratios 
(D). E) Cumulative production of sGAGs as detected by DMMB assay at 9 timepoints over 
30 days and F) evidence of aggrecan (green) in the cytoplasmic region with nuclei 
counterstained with DAPI (blue), SB: 200m. *: P<0.05. 
 
2.  Formulation of a deliverable fluid alginate 
An alginate fluid gel was produced by drop-wise addition of CaCl2 to sol alginate under 
shear. The fluid alginate architecture is characterized by fragments connected by ribbon-
like structures as shown in figure 4C.  Following shear ramps, the alginate fluid gel alginate 
showed a very small hysteresis loop indicating that this fluid material will be stable during 
manipulation and handling (Fig. 4B). After seeding of chondrocytes, they maintained a 
spherical morphology and showed high levels of viability (Fig. 4D and 4E).  
 
 
Figure 4. A) sol (left), quiescent (middle) and fluid (right) alginate B), change in shear 
stress with shear rate over continuous ramps of shear rate from 0.1-500-0.1-500-1, C) fluid 
gel architecture (SB: 200m), D) fluid gel with chondrocytes showing interaction with 
alginate fragments and ribbons SB: 100m), E) z-stack of chondrocytes in fluid alginate 4 
days after seeding, SB: 100m. 
 
 
Dynamic small deformation rheology was performed to determine the viscoelastic 
properties of both the alginate quiescent and fluid gel systems. The introduction of shear 
during the gelation process resulted in a reduction in the storage modulus of fluid alginate, 
when compared to the quiescent gels prepared under static conditions (in the absence of 
shear (Table 1)). The presence of weak interactions and entanglements are confirmed 
through linear rheology (Fig. 5B), with the sheared alginate showing solid-like behaviours 
dependent on frequency, typical of weak gels. Interestingly, the quiescent gel shows a 
similar mechanical spectrum (at higher G’ values) inferring structures which mirror each 
other, complementing data obtained via microscopy shown in Fig. 6. Changes throughout 
the gel microstructure were probed through stress sweeps (Fig. 5A), where shortening of 
the linear viscoelastic region (LVR) highlights the fluid gels ability to flow upon being 
stressed. Fluid alginate (closed circles) shows strong shear thinning behaviour (Fig. 5C), 
where increasing the shear to the systems causes reversible breakdown of the entangled 
polymers. However, this is not observed for the quiescent gel, as increasing shear to strains 
above the LVR causes fracturing of the gel resulting in artefacts that resemble thinning 
profiles (gel fracture points highlighted in Fig 5C using “#”). 
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Figure 5. A: Oscillatory stress sweeps (0.1-100 Pa, 1Hz, 37oC) showing variation in linear 
viscoelastic region (LVR). B: Mechanical spectra (0.5% strain, 37oC) showing variation in 
storage modulus (G’) and loss modulus (G’’). C: viscosity sweeps (0.001-100 s-1, 37oC). 
(Quiescent alginate: squares, fluid alginate: circles; G’: filled symbols, G’’: open symbols) 
 
Table I. Storage (G’), loss (G’’) and complex (G*) moduli of alginates. 
 Quiescent Fluid 
Hz / Pa G’ G’’ G* G’ G’’ G* 
0.1 615.87 34.45 616.83 146.3 27.84 148.93 
1 654.00 42.45 655.38 181.3 33.60 184.39 
10 727.13 76.72 731.17 247.3 68.21 256.82 
 
 
3. Microstructural observations of fluid and quiescent alginate 
To further understand the differences in structure between the two materials, their 
microstructures were observed using SEM following freeze drying. Fluid alginate was seen 
to have a less interconnected pore structure than quiescent alginate. Further, there were 
larger voidage regions observed throughout the fluid alginate structure that were not seen 
in the quiescent microstructure (Figure 6).  
 
 
Figure 6. SEM images of thin sections of quiescent (A,B) and fluid (C,D) following freeze 
drying 
 
 
4. Level of cell encapsulation in fluid and quiescent alginate 
To understand the level of encapsulation and confinement provided by alginate matrices of 
different structure, chondrocytes were imaged over time in culture. Individual chondrocytes 
in fluid gel were seen to move laterally across the field of view over a number of hours in 
the fluid alginate as well as downwards through the gel (Fig 7A, Video 7A – multimedia 
view). Chondrocytes in quiescent alginate however, did not show as much movement over 
the same time-course (Fig 7B, Video 7B – multimedia view). Cell movement was quantified 
by frame-by-frame tracking and then the gel drift caused by contraction of the gel was 
normalized. Cells in fluid gel were found to move further per frame than cells in the 
quiescent alginate, particularly the 25% most motile cells (Fig 7C and 7D). 
 
 
Figure 7. Tracking of chondrocytes in (A) fluid and (B) quiescent alginate over 14 hours. 
Movement of cells is demonstrated by coloured circles. Full videos are available in 
supplementary material, videos 7A and 7B (multimedia view). Quantification of chondrocyte 
movement in 2D in (C) fluid and (D) quiescent alginate. 
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5.  The effect of alginate fluid gel on the phenotype of primary articular chondrocytes 
To compare the efficacy of alginate fluid gel with quiescent alginate in supporting a 
chondrogenic phenotype, primary hACs were cultured in either alginate fluid gel or in 
quiescent alginate for a period of 7 days.  Following 7 days of culture collagen type II and 
aggrecan expression were higher in the quiescent than fluid alginate and sox9 expression 
was significantly higher in the quiescent alginate (Fig. 8).  
 
 
Figure 8. Relative mRNA expression of (A) collagen type II, (B) aggrecan (day 7) and (C) 
sox9 (day 7) in chondrocytes seeded in fluid and quiescent alginate. 
 
 
6.  Ex vivo cartilage explant tissue promotes the chondrogenic phenotype of primary 
chondrocytes encapsulated in quiescent alginate 
Due to the proximity of native cartilage tissue during the ACI repair of cartilage defects, ex 
vivo cartilage tissue and cartilage conditioned media were studied to determine their effect 
on the efficacy of using fluid and quiescent alginate as chondrocyte-carrying matrices. 
Following the encapsulation of a hAC population in quiescent alginate, the presence of a 
cartilage explant tissue (Fig. 9A) resulted in an increase in the expression of COL2A1 (Fig. 
9B) following 14 days of culture. The effect of the physical presence of cartilage tissue was 
shown to be secondary to the factors released from it (Fig. 9B), since conditioned cartilage 
explant media resulted in a greater increase (P=0.0376) in collagen type II expression than 
the cartilage tissue.  This suggests that in the in vivo environment, alginate encapsulation of 
hACs will be even more efficacious in promoting and maintaining the chondrogenic 
phenotype due to the secretion of endogenous anabolic factors from the surrounding 
cartilage matrix. This condition was then investigated to determine if it could be used to 
drive the native alginate phenotype in fluid alginate culture. However, when comparing 
conditioned and basal media, there was no significant difference between the conditions 
(P=0.3126, Fig. 9C); this further supports that physical entrapment of chondrocytes is 
critical to maintenance of the native collagen type II phenotype. 
 
Figure 9. A) Experimental set-up for explant (left) and blank/conditioned media (CM) (right). 
Relative collagen type II expression in B) quiescent and C) fluid alginate when cultured with 
basal media (blank), a cartilage explant or conditioned media. 
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Discussion 
Alginate has been investigated for cartilage repair and regeneration strategies over the last 
three decades since it has been shown to support the redifferentiation of chondrocytes that 
have lost their native collagen type II and proteoglycan-producing phenotype 27–29. The 
mechanism of this effect is relatively unknown but has been attributed to chondrocyte 
morphology, ligand adhesion as well as matrix mechanical properties 9,30. Here we aim to 
resolve the difference between the geometric and chemical influence of alginate.  
 
The findings of this study support previous observations that chondrocytes are not 
phenotypically stable in 2D culture on untreated tissue culture plastic, with freshly isolated 
primary human knee OA chondrocytes rapidly losing collagen type II expression and 
adopting a fibroblast-like morphology within 3 passages. This is a well-known phenomenon 
in chondrocyte culture, and has been attributed to the change in morphology when cultured 
on a stiff substrate 8,27,29.  In contrast, when primary chondrocytes were geometrically 
confined by encapsulation in quiescent alginate they maintained native morphologies 
depending on the construct region, akin to native chondrocytes in articular cartilage tissue 
31. Additionally, we found that primary human chondrocytes remained viable for up to 14 
days culture in quiescent alginate constructs. Importantly, our data demonstrates that this 
geometric confinement of human chondrocytes in quiescent alginate promotes a 
chondrogenic phenotype with maintenance of collagen type II expression and aggrecan 
proteoglycan production.  This data supports the finding of Murphy & Sambanis who 
showed that the maintenance of spherical chondrocyte morphology is necessary for 
recovery of the chondrogenic phenotype following monolayer culture 32. 
 
Since use of a quiescent alginate hydrogel construct for the regeneration of articular 
cartilage would require highly invasive surgery, we then examined whether alginate fluid 
gel, which would be more suitable for intra-articular injection, would exhibit the same 
chondrogenic promoting properties.  Using the same alginate solution as that used to 
produce the quiescent constructs, we introduced shear during its gelation with the same 
concentration of crosslinking cations. This produced a self-supporting network of gel 
microparticles referred to as alginate fluid gel 22,33. This gelation process was highly 
reproducible, with little variation between batches (Supp Fig. 1). Furthermore, rheological 
characterization demonstrated that with repeated frequency ramps there was a consistent 
shear stress. These non-time-dependent shear-thinning properties suggest that such 
alginate fluid-gel could be delivered by intra-articular injection without modification of its 
structural properties. Mechanically, alginate in its quiescent state was more elastic than  
fluid alginate and showed a higher complex modulus. The loss in elastic structure of the 
fluid alginate is attributed to the presence of shear throughout the sol-gel transition, where 
mixing prevents a complete network from forming 25. There were also differences in the 
liquid-like and frequency dependent properties of the two materials. Both materials were 
stable at lower frequencies, with the fluid alginate showing a shorter LVR as it can flow 
when stressed. Such a phenomenon arises through the prevention of a completely gelled 
network, allowing polymer strands to move freely once the required energy has been met to 
yield any weak inter-particle interactions or entanglements 21,25.  
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Following the investigation into the mechanical properties and the increased loss modulus 
of fluid alginate compared to quiescent alginate, the level of entrapment provided by the two 
alginate matrices was investigated. Using cell tracking, it was found that cells in fluid 
alginate were able to move laterally as well as vertically through the matrix whereas in 
quiescent alginate, cells were confined to distinct regions. It was observed that there was 
increased movement of chondrocytes observed after the gel had ‘drifted’. Therefore, this 
effect may be due to fluid flow through larger pores and voids in the fluid alginate structure 
that allows cells to move laterally through the gel network. This effect would be also be 
likely observed in an in vivo situation due to joint motion. Further, the difference in 
microstructure of the alginate may introduce local differences in the stiffness of the gel 
matrix resulting in changes to cell behavior. 
 
Despite the success of resuspending chondrocytes in alginate fluid gel and for cell viability 
to be maintained our study has found that fluid alginate was not as effective at maintaining 
chondrocyte phenotype as quiescent alginate upon culturing of constructs. This lack of 
effectiveness of fluid alginate to maintain and promote the chondrogenic phenotype of 
primary chondrocytes was even observed despite culturing hydrogels in the presence of 
explant conditioned growth media, which we had previously found significantly promoting 
collagen type II expression of primary chondrocytes in quiescent alginate hydrogels. As 
such, physical entrapment provided by the quiescent alginate gel has been shown to be 
critical in maintenance of a native chondrocyte phenotype. 
 
 
Conclusions 
By producing a chemically identical fluid alginate we have shown that with a lack of physical 
entrapment, passaged chondrocytes lose the ability to recover maintain their phenotype. 
Even the introduction of growth factors released from cartilage which have a significant 
increase in collagen type II expression in quiescent alginate have no effect. We have 
demonstrated that maintenance of a spherical morphology alone is insufficient to recover a 
native collagen type II phenotype in passaged adult human chondrocytes. A certain level of 
geometric confinement for the chondrocytes is also essential. 
 
 
 
 
 
 
 
 
  
 11
Methods 
 
Tissue sources and isolation of primary cells.  
Joint tissue was collected from OA patients undergoing elective knee replacement surgery.   
Ethical approval was provided by the United Kingdom National Research Ethics Service 
(East of Scotland Research Ethics Service (11/ES/1044). All patients or their families 
provided consent. Full-thickness cartilage was excised from the femoral condyle and 
cartilage explant discs generated by cork-boring.  For the isolation of primary human 
articular chondrocytes (hAC), cartilage was diced using a scalpel and digested in sterile-
filtered 2mg/ml collagenase type IA (0.5–3.0 FALGPA units/mg, Sigma Aldrich, Gillingham, 
UK) for 3 h. Both hACs and immortalised chondrocytes (TC28s) were cultured at 37°C in a 
humidified incubator in growth media (DMEM supplemented with 10% FCS, penicillin- 
streptomycin (100µg/ml), 2mM L-glutamine, and 1% non-essential amino acids, (Sigma 
Aldrich, Gillingham, UK)). For the generation of conditioned media, a cartilage disc 
(diameter: 4.1mm, depth: 2mm) was incubated with culture media for 24 h before being 
applied to cultures.  
 
Alginate preparation  
A solution of 1.5 wt% medium viscosity alginate was prepared by the addition of dH2O to 
sodium alginate (Sigma) and heating to 85°C for 1 h whilst stirring continuously. The 
solution was then allowed to cool to room temperature.  Fluid alginate was prepared by 
applying a shear rate of 500 s-1; 10% 200mM calcium chloride was added drop-wise and 
the solution equilibrated over 30 minutes at 20°C (AR-G2, TA Instruments, New Castle, DE, 
USA). All alginate used for cell culture was autoclaved prior to use. 
 
Encapsulation of chondrocytes in alginate.  
For quiescent gels, both immortal chondrocytes (TC28) and primary hACs were mixed with 
1.5 wt% alginate to a concentration of 1x106 cells/ml and seeded into the wells of a 96-well 
plate containing 0.2M CaCl2 with or without the presence of cartilage explant tissue. The 
quiescent gel was then incubated for 20 min at 37°C to allow crosslinking to occur. Gels 
were then rinsed twice with PBS, 0.2ml of chondrocyte growth medium added and then 
incubated at 37°C for up to 30 days. Conditioned media was generated from the 48 h 
incubation of femoral condyle cartilage explant tissue in chondrocyte growth media (15±3g 
in 30ml media). Alginate fluid gel was mixed with 1x106 hACs and pipetted into a 96-well 
plate. Media was changed twice a week. 
 
Determination of chondrocyte viability 
Cell viability in the alginate scaffolds was determined using a calcein AM/ethidium 
homodimer-1 LIVE/DEAD assay (Invitrogen). Calcein AM is cell-permeable and is 
hydrolysed to green fluorescent calcein by interaction with intra-cellular enzymes; cell-
impermeable ethidium homodimer-1 binds to DNA and fluoresces red so binds to the DNA 
of dead/dying cells. Alginate constructs were imaged on a Leica DM 6000B confocal 
microscope.  
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RNA isolation and quantification 
Total RNA was isolated from alginate constructs and from chondrocyte monolayer cultures 
using TRIzol® reagent (Life Technologies, UK). In brief, alginate constructs were 
homogenized in 1ml TRIzol reagent using a TissueRuptor (Qiagen). Chondrocyte 
monolayer cultures in 6-well plates were directly lysed with 1ml of TRIzol reagent per well. 
Following the addition of TRIzol, 0.2ml chloroform was added and the samples shaken 
vigorously for 15 seconds before being centrifuged for 15 minutes a 12,000 x g for the 
phase separation of RNA, DNA and protein. The aqueous (RNA containing) phase was 
decanted and RNA precipitated overnight at -20C by the addition of 0.5ml isopropanol. 
Following centrifugation the RNA pellet was washed in ethanol, dried, and resuspended in 
50l RNase-free H2O. RNA concentrations and A260/280 ratio were determined using 
spectrophotometry (NanoDrop 2000, ThermoScientific). RNA was stored at -80°C prior to 
analysis by qRT-PCR. 
 
Quantitative real-time PCR 
Precision OneStep SYBR Green Dye (PrimerDesign) was used with a β-actin reference 
gene (PrimerDesign) for quantification of the mRNA expression of COL1A1, COL2A1, 
ACAN and SOX9 genes. The forward and reverse primer sequences were designed using 
Primer Express 3 software (Applied Biosystems) and produced by LifeTechnologies or 
PrimerDesign as indicated alongside primer sequences shown in Supplementary Table 1. 
Relative gene expression was determined by ddCT, normalized to β-actin. 
 
Quantification of aggrecan proteoglycan 
As a marker of aggrecan proteoglycan production, sulphated glycosaminoglycans (sGAG) 
released by the scaffolds into the supernatants were measured using a 1,9-
dimethylmethylene blue (DMMB) assay 34. Supernatant samples (50l) at 3, 7, 10, 14, 17, 
21, 24, 27 and 30 days and standards of shark chondroitin sulphate dilutions were added to 
200l DMMB colour reagent at pH3. Alginate alone served as a control to remove the effect 
of interference of uronic acid groups in alginate. The absorbance was read immediately at 
A540 using a BioTek EL808 plate reader. 
 
Immunohistochemical analysis 
For immunohistochemistry, cellular scaffolds were cultured for two weeks before analysis. 
Scaffolds were then fixed with 4% paraformaldehyde for 10 minutes before blocking in 0.1M 
PBS with 10% goat serum and 0.3% Triton-X-100. Aggrecan was detected using mouse 
anti-aggrecan primary antibody (1:200, ThermoFisher) and then Alexa-488 goat anti-mouse 
secondary antibody (1:500, Invitrogen). Nuclei were counterstained with DAPI (1:5000, 
Sigma Aldrich).  
 
Characterization of fluid and quiescent alginate 
To visualize the ‘architecture’ of the fluid gel, it was mixed in a 1:4 ratio with PEG to provide 
contrast between the phases and imaged using light microscopy (Leica DM 6000B).  
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Oscillatory rheology was used to determine the mechanical properties of fluid and quiescent 
alginate of the same chemistry. Discs (40mm diameter) of quiescent alginate were 
produced using 0.2M CaCl2 by the filter paper method described elsewhere 35. Fluid 
alginate samples were tested using a parallel, 40mm sandblasted geometry while quiescent 
alginate samples were prepared as 40mm discs and tested using a ridged mesh as a 
gripper on flat 40mm parallel plates on a AR-G2 Rheometer (TA Instruments, USA). A 
strain sweep was performed to determine the linear viscoelastic range of the gels. Storage 
(G’) and loss (G’’) moduli were determined at a range of oscillatory frequencies (0.1-100Hz) 
at 0.5% strain at 37°C. Complex modulus (G*) was calculated by: 
     G∗ ൌ ඥሺGᇱሻଶ ൅ ሺGᇱᇱሻଶ Equation 1  
 
angular frequency () was calculated by: 
     ω ൌ 2πሺHzሻ     Equation 2 
 
 
To determine any changes in structure during experimental procedures, the response to 
shearing as experienced by fluids moving through a pipette tip was modeled by ramping the 
shear rate from 0.1-500-0.1-500-0.1 s-1 at 0.5% strain. Oscillatory stress ramps were 
performed to determine the LVR of each alginate matrix.   
 
Scanning electron microscopy (SEM) 
1mm thick sections of quiescent alginate and 1mm smears of fluid alginate were snap 
frozen in liquid nitrogen and dried under vacuum for 48 hours (Mini Lablyo, Frozen in Time 
Ltd., York, UK). They were then mounted using conductive carbon tape and gold sputter 
coated. The topography was then imaged using a TM3030Plus benchtop SEM (Hitachi 
High Technologies, Schaumburg, USA) at 15kV. 
 
Cell tracking 
Cell tracking was used to determine the level of entrapment provided by the different 
alginate matrices. Chondrocytes were seeded in fluid and quiescent alginate at 1x106 
cells/ml and imaged every 5 minutes at 3 z-positions in each well over 20 hours using a 
Cell-iQ and accompanying software Cell-iQ Imagen and Cell-iQ Analyser (Chip-Man 
Technologies, Tampere, Finland). Cell movement was quantified by tracking individual cells 
frame-by-frame using Cell-iQ Analyser. The trajectories were mapped and the movement in 
2D was normalized from gel drift (contraction) by tracking a reference point in each frame. 
 
 
Statistical analysis 
Mean values and standard error of the mean are plotted. Unpaired t-tests were performed 
using Prism 7 (GraphPad software, California, USA) with significance of p<0.05. 
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Supplementary Material 
See supplementary material for viscosity profiles of fluid alginate as it is produced as well 
as primer sequences and cell tracking videos. 
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